Genaissance Will Provide Genotyping Services for Cyprus Scrapie Contract
Genaissance Pharmaceuticals, Inc. announced that it will provide its high-throughput Genotyping services to Biotronics Ltd., headquartered in Nicosia, Cyprus, which has been awarded a contract by the Veterinary services in the Ministry of agriculture, Natural Resources & Environment as part of Cyprus' efforts to implement the European Union's (EU) mandate for establishing a breeding program in sheep that confers resistance to scrapie. Under the terms of the contract, Biotronics will collect the tissue specimens from the Veterinary Services and send them to Genaissance's genotyping facility in New Haven, CT, where Genaissance will analyze a minimum of 100,000 samples over approximately a three-month period of time.
Most read news
Organizations
Other news from the department business & finance

Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.